Stockreport

Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching the [Read more]